+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celltrion - logo

Celltrion manufacturers and sells biopharmaceutical and chemical medicines. Its best known products Remsima, a monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis and adult Crohn's disease. Its antibody biosimilar pipeline includes CT-P10, CT-P17, CT-P16 and others. While its antibody biologics pipeline comprises CT-P27, CT-P26 and CT-P19. The company was founded in 2002 and is headquartered in Incheon, South Korea.

Thematic Intelligence - Biosimilars in oncology - Product Thumbnail Image

Thematic Intelligence - Biosimilars in oncology

  • Report
  • December 2023
  • 76 Pages
  • Global
From
From
From
From
From
Breast Cancer Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Breast Cancer Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer - Global Strategic Business Report

  • Report
  • July 2025
  • 582 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) Treatment Market Report 2025 - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Stomach Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Stomach Cancer Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 371 Pages
  • Global
From
From
From
Gastric Cancer Drugs Market 2025-2029 - Product Thumbnail Image

Gastric Cancer Drugs Market 2025-2029

  • Report
  • May 2025
  • 217 Pages
  • Global
From
Targeted Oncology Therapeutics: Hematology Cancers - Product Thumbnail Image

Targeted Oncology Therapeutics: Hematology Cancers

  • Report
  • October 2021
  • 110 Pages
  • Global
From
Loading Indicator